Professional Documents
Culture Documents
Clinical Manifestations and Diagnosis of Scleritis - UpToDate
Clinical Manifestations and Diagnosis of Scleritis - UpToDate
All topics are updated as new evidence becomes available and our peer review process is complete.
INTRODUCTION
Scleritis is a painful, destructive, and potentially blinding inflammatory disorder of the sclera
that may also involve the cornea, adjacent episclera, and underlying uveal tract. Scleritis has
a striking, highly symptomatic clinical presentation ( picture 1) (see 'Clinical features'
below). By contrast, episcleritis is typically self-limited or quickly responsive to topical
therapies. (See "Episcleritis".)
This topic will review the clinical manifestations and diagnosis of scleritis. The treatment of
scleritis, episcleritis, and issues related to other inflammatory disorders of the eye are
presented separately. (See "Treatment of scleritis" and "Episcleritis" and "Uveitis: Etiology,
clinical manifestations, and diagnosis" and "Ocular manifestations of rheumatoid arthritis"
and "Retinal vasculitis associated with systemic disorders and infections".)
ANATOMY
The sclera lies beneath the conjunctiva and episclera but above the choroid ( figure 1). The
opaque scleral tissue is composed of collagen fibrils arranged in a precise, interlacing
manner that enhances rigidity and stability. Although the sclera itself is avascular, the tissue
derives its metabolic requirements by diffusion from the episclera and choroid, both of which
are highly vascularized.
The sclera comprises 90 percent of the outer coat of the eye. Scleral tissue begins at the
limbus (the outer edge of the cornea) and terminates posteriorly at the optic canal. At the
posterior pole of the eye, the sclera fuses with the dura mater and arachnoid sheaths of the
optic nerve. These anatomic relationships explain why optic nerve edema and visual
compromise are common complications of posterior scleritis ( picture 2). (See 'Clinical
features' below.)
The sclera is divided into an anterior portion that is visible to the examiner and a posterior
portion that lies behind the globe. Inflammation may occur in either the anterior or the
posterior portion; rarely, it affects both, particularly in the setting of systemic inflammation.
Anterior scleritis and posterior scleritis have different sets of implications for diagnosis,
treatment, and prognosis.
SCLERITIS SUBTYPES
Approximately 90 percent of scleritis cases involve the anterior portion of the sclera.
Posterior scleritis is defined as involvement of the sclera by inflammation posterior to the
insertion of the medial and lateral rectus muscles. Diffuse, nodular, and necrotizing subtypes
of both anterior and posterior scleritis are recognized. (See 'Anterior scleritis' below and
'Posterior scleritis' below.)
● Diffuse anterior scleritis – Diffuse anterior scleritis is the most common and least
severe form of scleritis, accounting for nearly 50 percent of cases ( picture 3). Most
cases respond to relatively mild therapies and do not recur. (See 'Clinical features'
below and "Treatment of scleritis".)
● Nodular anterior scleritis – Nodular anterior scleritis is the second most common
form of anterior scleritis, accounting for 20 to 40 percent of cases ( picture 4).
Multiple attacks of scleritis occur in approximately 50 percent of patients. (See 'Clinical
features' below.)
● Necrotizing anterior scleritis – Necrotizing anterior scleritis is the least common but
most dangerous subtype of anterior scleral inflammation. Compared with diffuse or
nodular scleritis, this disorder occurs more frequently in females, has an older mean
age of onset (average age 66 years), is more often associated with a systemic
inflammatory illness, and is more likely to lead to ocular complications.
Posterior scleritis — Diffuse, nodular, and necrotizing variants of posterior scleritis have
also been identified, but the clinical distinction between these entities is more difficult due to
anatomic challenges involved in the assessment of posterior scleritis [3,4].
Because of the delays inherent in diagnosing an inflammatory process focused behind the
eye and the proximity of posterior scleral inflammation to sensitive ocular tissues (eg, the
retina and optic nerve), posterior scleritis usually requires the types of intensive
immunosuppressive therapy used in necrotizing anterior scleritis. (See "Treatment of
scleritis".)
PATHOGENESIS
An important underlying role for vasculitis in patients with necrotizing scleritis is illustrated
by a study in which conjunctival and scleral biopsies from 25 patients with necrotizing
scleritis and five with recurrent non-necrotizing scleritis were evaluated [5]. The patients had
histopathologic evidence of vasculitis, with fibrinoid necrosis and neutrophil invasion of
blood vessel walls and immune complex deposition in vessels from both scleral specimens,
which include the episcleral tissue, and conjunctival specimens.
Specific types of systemic diseases that are associated with scleritis include the following
( table 1):
● Infection – Systemic infections associated with scleritis include herpes zoster [12] and,
less commonly, Lyme disease [13], tuberculosis [14], syphilis [15], and aspergillus [16].
(See "Tuberculosis and the eye" and "Neurosyphilis".)
● Local trauma – Local trauma may also be a contributing factor. Scleritis may first occur
after ocular surgery, perhaps initiated by trauma to the sclera [17-19]. The risk may be
greater in patients with underlying rheumatic disease [17,18].
CLINICAL FEATURES
Ocular symptoms — Scleritis is usually characterized by severe, constant, boring pain that
worsens at night or in the early morning hours and radiates to the face and periorbital
region. The extraocular muscles insert into the sclera; thus, ocular movements exacerbate
the pain associated with scleral inflammation. The pain generally limits activity and often
prevents sleep. Additionally, patients may report headache; watering of the eye; ocular
redness, particularly in patients with non-necrotizing anterior scleritis; and photophobia,
which is variably present. Symptoms may vary depending upon the severity of scleritis that is
present and whether there is tissue necrosis. When there is tissue necrosis in severe disease,
there is loss of peripheral innervation, which leads to "paradoxic" lessening of symptoms:
● Diffuse and nodular anterior scleritis – Diffuse and nodular anterior scleritis are the
most common forms of scleritis and the clinical types most commonly associated with
pain and discomfort as described above.
a change in the shape of the eyeball and an alteration of corneal curvature (an
acquired astigmatism).
The findings on ophthalmologic examination depend upon the type, severity, and location of
the scleritis. (See 'Ocular examination' below.)
The different subtypes of scleritis are associated with variable presentations and distinctive
findings on physical examination:
● Nodular anterior scleritis – Localized areas of firm, tender edema associated with
intense dilation of the deep episcleral vessels may be found in nodular anterior scleritis
( picture 4). With treatment, the pain and scleral tenderness resolve rapidly; however,
the nodules may persist for months.
● Necrotizing anterior scleritis – There are two types of necrotizing anterior scleritis,
termed necrotizing anterior scleritis with inflammation and scleromalacia perforans.
Involvement of other ocular structures — In addition to the sclera, other ocular tissues
may be involved in scleral inflammatory disease:
● Uveal tract – Anterior uveitis occurs in up to 40 percent of eyes involved by scleritis and
may lead to additional management considerations, eg, the use of glucocorticoid
eyedrops. This is thought to be primarily a form of "spillover" inflammation, rather than
a primary involvement of the uveal tract.
● Lens – Cataract formation is related to the severity of the scleritis. It primarily occurs in
necrotizing scleritis, affecting approximately 20 percent of such patients. The incidence
of cataract is much lower (less than 5 percent) with other subtypes of scleritis.
Features of systemic disease — Although the ocular complaints and findings are the most
prominent disease feature for many patients with scleritis, critical clues to the presence of a
systemic inflammatory condition may be present on the general history and physical
examination. (See 'Systemic disease associations' above.)
DIAGNOSIS
The diagnosis of scleritis has two major elements. These are the diagnosis of scleritis itself
(see 'Diagnosis of scleritis' below) and the diagnostic evaluation to establish or exclude the
presence of an associated systemic disorder (see 'Diagnostic evaluation for systemic disease'
below). The latter evaluation can sometimes influence the approach to diagnosis and
classification of the scleritis itself and affect the approach to therapy.
Posterior scleritis, which is usually not accompanied by anterior scleritis, differs from
anterior scleritis in that the eye appears "quiet," meaning white and uninflamed on external
examination, rather than violaceous or red. The other findings of posterior scleritis, such as
choroidal thickening and other changes such as exudative retinal detachment (see 'Ocular
examination' above), are difficult for the non-ophthalmologist to identify, as they need full
posterior segment ophthalmoscopy. In addition to slit-lamp examination and
ophthalmoscopy, B-scan ultrasonography of the posterior pole is used to detect
characteristic changes in posterior scleritis.
Anterior scleritis is usually readily apparent to both the patient and clinician and can be
diagnosed and classified based upon its clinical features, elicited in the history and evident
on the ophthalmologic examination (see 'Clinical features' above). By comparison, posterior
scleritis is often less apparent and has variable clinical manifestations that may overlap on a
spectrum with other clinical entities, such as inflammatory orbital "pseudotumor" [3,4].
● History – The history should include questions to elicit the eye-related symptoms and
findings observed by the patient, including pain and its characteristics, including
radiation; whether pain is worse with eye movement; symptoms of visual disturbance;
and ocular redness. The duration and acuity of symptoms is an important feature to
ascertain, given the typical subacute presentation in most patients. In addition, patients
should be questioned regarding symptoms or findings of associated systemic disease
that may further increase the likelihood of the diagnosis. (See 'Diagnostic evaluation for
systemic disease' below.)
● Eye examination – All patients suspected of scleritis should be urgently referred for
evaluation by an ophthalmologist for a diagnostic evaluation that typically includes a
slit-lamp examination as well as ophthalmoscopy. Patients who should generally
undergo such ophthalmologic evaluation also include those with exophthalmos,
especially unilateral or asymmetric exophthalmos (or proptosis), in whom the
presentation is not thought to be due to dysthyroid disease (Graves).
● Imaging to evaluate scleritis – Several types of imaging studies may be used by the
ophthalmologist in the evaluation of scleritis, depending upon the symptoms and
findings:
Diagnostic evaluation for systemic disease — All patients with suspected scleritis should
undergo a thorough evaluation for an associated systemic condition. This evaluation is
typically performed by a rheumatologist. This should include:
● History and examination – Although the ocular complaints and findings are the most
prominent disease feature for many patients with scleritis, critical clues to the presence
of a systemic inflammatory condition may be present on the general history and
physical examination.
The clinician should question the patient regarding any history of rheumatoid arthritis
(RA) or other systemic autoimmune or inflammatory condition that may be associated
with scleritis ( table 1), such as GPA and, less often, other antineutrophil cytoplasmic
antibody (ANCA)-associated vasculitides; inflammatory bowel disease; systemic lupus
erythematosus; relapsing polychondritis; spondyloarthritis; or recent eye surgery.
• Routine tests
- Serum chemistry profile – This should include creatinine, blood urea nitrogen,
electrolytes, albumin, total protein, and aminotransferases.
- Acute phase reactants – Patients with scleritis associated with a systemic illness
are likely to have extremely high acute phase reactants. Both the erythrocyte
sedimentation rate (ESR) and serum C-reactive protein (CRP) should be checked.
These markers may also be useful in following responses to therapy and in
detecting disease flares.
- ANCA testing – ANCA assays are likely to be positive in patients with GPA,
microscopic polyangiitis, or eosinophilic granulomatosis with polyangiitis (eGPA,
Churg-Strauss), particularly in cases associated with scleritis. (See "Clinical
spectrum of antineutrophil cytoplasmic autoantibodies".)
● Imaging studies – Chest radiography (plain films) should be performed in all patients
to exclude infiltrates and nodules that might be associated with vasculitis, sarcoidosis,
or infections such as tuberculosis. Abnormal findings on chest radiographs should be
defined further with CT examination of the lungs and other imaging as required.
DIFFERENTIAL DIAGNOSIS
The differential diagnosis of conditions that may cause eye pain or redness of the eye is
broad, but an expert ophthalmologic examination is generally the key element in the
evaluation to distinguish scleritis from other diagnostic possibilities. The differential
diagnosis of the red eye encompasses the conditions that should be considered in the
differential diagnosis of scleritis and is discussed in detail separately. (See "The red eye:
Evaluation and management".)
Links to society and government-sponsored guidelines from selected countries and regions
around the world are provided separately. (See "Society guideline links: Uveitis".)
SUMMARY
● Scleritis subtypes – Scleritis is a painful, destructive disorder that may cause visual loss
and may also be associated with inflammation in other parts of the eye, such as the
cornea, episclera, and uveal tract. The sclera is divided into an anterior and posterior
portion. Anterior scleritis and posterior scleritis have different sets of implications for
diagnosis, treatment, and prognosis. (See 'Introduction' above and 'Scleritis subtypes'
above.)
● Pathogenesis
● Clinical features
• Ocular symptoms and examination – Anterior scleritis (with ocular erythema and
other examination features as well as intense pain) is usually obvious to both the
patient and clinician. Posterior scleritis is less obvious, as redness and other changes
are often not seen on examination. (See 'Ocular symptoms' above and 'Ocular
examination' above.)
● Diagnosis
ACKNOWLEDGMENT
The UpToDate editorial staff acknowledges John Stone, MD, who contributed to an earlier
version of this topic review.
REFERENCES
2. Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and
treatment results. Am J Ophthalmol 2000; 130:469.
3. McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic
associations, and outcome in a large series of patients. Ophthalmology 1999; 106:2380.
7. Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic
disease. Ophthalmology 2004; 111:501.
8. Busnelo Moreno C, Gonçalves Cruz JC, Zotarelli-Filho IJ, et al. Necrotizing Scleritis and
Rheumatoid Arthritis: A Clinical Case Report Supported by A Brief Review with Risk of
Bias Analysis. Curr Rheumatol Rev 2023; 19:367.
9. Lin WV, Saumur M, Al-Mohtaseb Z. Scleritis, keratitis, and orbital cellulitis: isolated ocular
manifestation of systemic lupus erythematosus. Lupus 2018; 27:1985.
10. Sainz-de-la-Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Scleritis associated with
relapsing polychondritis. Br J Ophthalmol 2016; 100:1290.
11. Hoang LT, Lim LL, Vaillant B, et al. Antineutrophil cytoplasmic antibody-associated active
scleritis. Arch Ophthalmol 2008; 126:651.
12. Tranos PG, Ong T, Nolan W, et al. Posterior scleritis presenting with annular choroidal
detachment as a complication of herpes zoster ophthalmicus. Retina 2003; 23:716.
13. Berkenstock MK, Long K, Miller JB, et al. Scleritis in Lyme Disease. Am J Ophthalmol
2022; 241:139.
14. Sainz de La Maza M, Hernanz I, Moll-Udina A, et al. Presumed tuberculosis-related
scleritis. Br J Ophthalmol 2023; 107:495.
15. Casey R, Flowers CW Jr, Jones DD, Scott L. Anterior nodular scleritis secondary to syphilis.
Arch Ophthalmol 1996; 114:1015.
16. Fincher T, Fulcher SF. Diagnostic and therapeutic challenge of Aspergillus flavus scleritis.
Cornea 2007; 26:618.
17. Sainz de la Maza M, Foster CS. Necrotizing scleritis after ocular surgery. A
clinicopathologic study. Ophthalmology 1991; 98:1720.
18. Díaz-Valle D, Benítez del Castillo JM, Castillo A, et al. Immunologic and clinical evaluation
of postsurgical necrotizing sclerocorneal ulceration. Cornea 1998; 17:371.
19. Scott JA, Clearkin LG. Surgically induced diffuse scleritis following cataract surgery. Eye
(Lond) 1994; 8 ( Pt 3):292.
20. Dursun D, Akova YA, Bilezikçi B. Scleritis associated with sarcoidosis. Ocul Immunol
Inflamm 2004; 12:143.
21. Soukiasian SH, Foster CS, Raizman MB. Treatment strategies for scleritis and uveitis
associated with inflammatory bowel disease. Am J Ophthalmol 1994; 118:601.
22. Squirrell DM, Winfield J, Amos RS. Peripheral ulcerative keratitis 'corneal melt' and
rheumatoid arthritis: a case series. Rheumatology (Oxford) 1999; 38:1245.
23. Pakrou N, Selva D, Leibovitch I. Wegener's granulomatosis: ophthalmic manifestations
and management. Semin Arthritis Rheum 2006; 35:284.
24. Lin P, Bhullar SS, Tessler HH, Goldstein DA. Immunologic markers as potential predictors
of systemic autoimmune disease in patients with idiopathic scleritis. Am J Ophthalmol
2008; 145:463.
Topic 5599 Version 26.0
GRAPHICS
Bilateral scleritis
Bilateral anterior scleritis in a patient with Cogan syndrome, manifested by ocular pain and erythema.
(The patient also had vertigo and bilateral sensorineural hearing loss as a complication of her Cogan
syndrome.)
Posterior scleritis
Posterior scleral wall inflammation with involvement of the optic disc. The disc margin is blurred in
association with vascular engorgement and flame-shaped nerve fiber layer hemorrhages.
Nodular anterior scleritis in a patient with rheumatoid arthritis. Nodular elevation of the sclera is
surrounded by deep scleral vascular engorgement.
Acute necrotizing scleritis with inflammation in a patient with rheumatoid arthritis. Anterior bulging of
the inflamed sclera is seen in association with scleral thinning due to necrosis.
Chronic necrotizing anterior scleritis with inflammation in a patient with granulomatosis with
polyangiitis. Significant thinning of the sclera permits the visualization of the underlying choroid
through the scleral wall.
Scleromalacia perforans
Scleromalacia perforans in a patient with rheumatoid arthritis. There are areas of significant collagen
breakdown in the scleral wall with little to no associated redness or vascular engorgement.
Rheumatoid arthritis
Reactive arthritis
Relapsing polychondritis
Systemic vasculitides
Granulomatosis with polyangiitis
Microscopic polyangiitis
Polyarteritis nodosa
Cogan syndrome
Behçet syndrome
Urticarial vasculitis
Infections
Syphilis
Tuberculosis
Lyme disease
Herpes zoster
Aspergillis
Other
Sarcoidosis
Antinuclear antibody
Syphilis serologies
Rheumatoid factor
Urinalysis
Skin tests
Tuberculin skin test
Allergy tests
Radiologic testing
Chest radiograph
These recommendations should be modified as dictated by the findings of a thorough history, review
of systems, and physical examination.